Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is an anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, postherpetic neuralgia, diabetic peripheral neuropathic pain and restless legs syndrome in adult patients across the European Union market.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neurontin (gabapentin) is employed to manage neurological pain and seizure disorders.

Partial seizures: Reduces the frequency and severity of focal seizures. Postherpetic neuralgia: Alleviates chronic pain following shingles infection. Diabetic peripheral neuropathic pain: Decreases pain intensity in diabetic neuropathy. Restless legs syndrome: Improves uncomfortable sensations and urges to move the legs.

Common Side Effects: - Dizziness: Sensation of light‑headedness or unsteadiness. - Somnolence: Excessive sleepiness or fatigue. - Peripheral edema: Swelling of the lower limbs. - Visual disturbances: Blurred vision or double vision.

Serious or Rare Side Effects: - Severe allergic reaction: Rash, swelling, or difficulty breathing. - Suicidal thoughts: New or worsening depression or suicidal ideation. - Acute respiratory depression: Marked breathing difficulty, especially when combined with CNS depressants.

Neurontin should be used with caution in patients with renal impairment, as dosage adjustment may be required. - Pregnancy: Safety not established; discuss risks with a healthcare professional. - Breastfeeding: Gabapentin may be excreted in breast milk; evaluate benefits versus risks. - CNS depression: Avoid alcohol and other sedatives that may enhance drowsiness. - Withdrawal: Do not discontinue abruptly; taper under medical supervision. - Store at ambient temperature: Keep below 25 °C in the original container, protected from moisture and light.

Potential drug interactions can affect efficacy or increase adverse effects.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: Reduce gabapentin absorption. - Opioids: Heightened risk of respiratory depression and sedation.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): May increase dizziness and somnolence. - Diuretics: May enhance risk of peripheral edema. - Anticonvulsants (e.g., carbamazepine): May lower gabapentin plasma levels.